Evidence of the further importance of mTOR or its downstream targets has come from studies showing that OSI027, which binds to the catalytic site of mTOR and blocks its kinase function, inhibits tumor growth and down regulates phospo-4eBP1 in xenografts models. This evidence concerns the gene EIF4EBP1 and neoplasm.